News
LEXINGTON, Ky. (Nov. 29, 2021) — For this “UK at the Half,” Lisa Cassis, vice president for research at the University of Kentucky, shares how leaders across campus came together to find a path forward for research during the COVID-19 pandemic.
LEXINGTON, Ky. (Nov. 22, 2021) — What makes UK the university of, for and with Kentucky?
The answer is our people.
Timothy Mullett, M.D., a University of Kentucky professor of cardiothoracic surgery and the medical director of the UK Markey Cancer Center Affiliate and Research Networks, joined Gov. Andy Beshear and a number of lung cancer advocacy groups at the state Capitol to recognize November as Lung Cancer Awareness Month.
Gov. Beshear encouraged Kentuckians to learn more about lung cancer, its risk factors and screening options.
LEXINGTON, Ky. (Nov. 11, 2021) — Researchers at the University of Kentucky’s Sanders-Brown Center on Aging recently received a five-year grant renewal of their MarkVCID program from the National Institutes of Health (NIH). The award total is more than $6 million.
The University of Kentucky College of Medicine recently welcomed Ilhem Messaoudi, PhD, as the new chair of microbiology, immunology, and molecular genetics. She shares more about her work to better understand viruses and the wide range of factors affecting the immune system. She also shares how her research career led her to UK.
Q: Why did you pursue a career in research?
LEXINGTON, Ky. (Nov. 2, 2021) — A recent study shows that patients with non-small cell lung cancer reviewed by the University of Kentucky Markey Cancer Center’s Molecular Tumor Board experience improved outcomes, even if they reside in rural Appalachian Kentucky.
Roberto Gedaly, MD, and Francesc Marti, PhD, investigators in the University of Kentucky College of Medicine Department of Surgery, have noticed a year-over-year increase in liver transplants at UK HealthCare.
“Not only has our volume gone up significantly,” Dr. Gedaly said, “we’re actually going to break a record of liver transplant patients this year.”
LEXINGTON, Ky. (Oct. 21, 2021) — The University of Kentucky Markey Cancer Center has been awarded a transportation grant from the American Cancer Society. The funds will help alleviate the financial burden of transportation costs for cancer patients in Kentucky.
LEXINGTON, Ky. (Oct. 21, 2021) — A recent University of Kentucky College of Medicine study found that young adults from vulnerable communities are more likely to be exposed to tobacco marketing in their daily lives than are young adults outside these communities.
The University of Kentucky College of Medicine has received the 2021 Health Professions Higher Education Excellence in Diversity (HEED) Award from INSIGHT Into Diversity magazine, the oldest and largest diversity-focused publication in higher education.
LEXINGTON, Ky. (Oct. 8, 2021) — A recently released paper from the Department of Physiology and Sanders-Brown Center on Aging (SBCoA) at the University of Kentucky College of Medicine suggests that your genetics can influence your response to Alzheimer’s disease pathology.
LEXINGTON, Ky. (Oct. 6, 2021) — A new study from the lab of University of Kentucky Markey Cancer Director Mark Evers, M.D., demonstrates the critical role of the hormone neurotensin in cell proliferation and stem cell function in the small intestine.
LEXINGTON, Ky. (Oct. 6, 2021) — Recent work from the University of Kentucky College of Medicine published in Cell Press discusses an essential signaling pathway that causes metabolic dysfunction including insulin resistance and obesity.
LEXINGTON, Ky. (Oct. 5, 2021) — University of Kentucky College of Medicine researchers were part of a new study that gives insight into how limb development evolved in vertebrates.
Brian Higgins, PhD, has been named one of the few medical educators across the world selected for this year’s prestigious Harvard Macy Institute Program for Educators in Health Professions.
Through the annual Harvard program, Dr. Higgins will learn evidence-based teaching strategies, tips for effective curriculum design, leadership styles, and other skills that will be useful not only for his own teaching, but for the University of Kentucky College of Medicine as a whole.
LEXINGTON, Ky. (Sept. 28, 2021) — A new study from University of Kentucky Markey Cancer researchers demonstrates a combination of two drugs may be useful to treat ovarian cancers that are resistant to paclitaxel.
LEXINGTON, Ky. (Sept. 27, 2021) — University of Kentucky’s Saha Cardiovascular Research Center recently held its annual Cardiovascular Research Day, an event that showcases innovative research in cardiovascular health. The event features prominent speakers in the field of cardiovascular health and was the first in-person scientific conference in the field of lipid and lipoprotein metabolism and cardiovascular disease in nearly two years.
LEXINGTON, Ky. (Sept. 14, 2021) — What if there were a way to cure hypertension associated with obesity? University of Kentucky researcher Frédérique Yiannikouris, Ph.D., an assistant professor in the University of Kentucky College of Medicine's Department of Pharmacology and Nutritional Sciences, may be on track to find it.
LEXINGTON, Ky. (Sept. 9, 2021) — On Aug. 24, 2021, University of Kentucky senior Zakeya Baker sat down with health experts Becky Dutch, Ph.D, and Alice Thornton, M.D., to ask questions about COVID-19, vaccines and UK’s response to the virus. Dutch and Thornton addressed concerns common to students as well as many individuals across the globe.
LEXINGTON, Ky. (Sept. 2, 2021) — As part of National Ovarian Cancer Awareness Month, Kentucky Lt. Gov. Jacqueline Coleman and several of Kentucky’s female legislators joined UK HealthCare to highlight the long-running work of the University of Kentucky Markey Cancer Center's Ovarian Cancer Screening Program.